Cite
HARVARD Citation
Wang, M. et al. (2015). Combined therapy with Xuezhikang and low-dose rosuvastatin provides an effective and safe therapeutic strategy for dyslipidemic patients. Clinical lipidology. pp. 243-250. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Wang, M. et al. (2015). Combined therapy with Xuezhikang and low-dose rosuvastatin provides an effective and safe therapeutic strategy for dyslipidemic patients. Clinical lipidology. pp. 243-250. [Online].